U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07329036) titled 'ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF' on Feb. 29, 2024.

Brief Summary: The artificial liver support system (ALSS) in patients with acute on chronic liver failure - the use of combined molecular adsorption system with double plasma (DPMAS) and therapeutic plasma exchange (TPE), its effect on primary coagulation, inflammation and the function of vital organs.

Study Start Date: April 01, 2024

Study Type: INTERVENTIONAL

Condition: Acute Liver Failure

Intervention: DEVICE: The artificial liver support system (ALSS) - DPMAS...